Concepedia

Wanli Meng

WM

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2022

Affiliations

Berry Oncology (China)(Current)

Wanli Meng is an author at Berry Oncology (China) specializing in molecular genetics, mutation analysis, and genomics.

Publications per year

2022–2023

4

Publications

4

Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the <i>FMR1</i> Locus by Long-Read Sequencing

Qiaowei Liang, Yingdi Liu, Yaning Liu et al. · Clinical Chemistry · 2022 · 36 citations · Full text

, , +17

Identification of a novel 10.3 kb deletion causing α0-thalassemia by third-generation sequencing: Pedigree analysis and genetic diagnosis

Runhong Xu, Hui Li, Yi Song et al. · Clinical Biochemistry · 2023 · 12 citations

, , +17

A high-fidelity long-read sequencing-based approach enables accurate and effective genetic diagnosis of spinal muscular atrophy

Jin-li Bai, Yu-jin Qu, Wen‐Chen Huang et al. · Clinica Chimica Acta · 2023 · 12 citations

, , +15

The comprehensive analysis of thalassemia alleles (CATSA) based on single-molecule real-time technology (SMRT) is a more powerful strategy in the diagnosis of thalassemia caused by rare variants

Jianjiang Feng, Di Cui, C Li et al. · Clinica Chimica Acta · 2023 · 10 citations

, , +17

1–4 of 4